{"schema":"hottub-news/story/v1","story":"st_z4rzpnqc7gnocr6dup3a","title":"GKV-Spitzenverband kritisiert Pharma-Standortklausel","title_en":"GKV-Spitzenverband criticizes Pharma-Standortklausel","outlets":1,"brief":null,"page":"https://hottub.news/stories/gkv-spitzenverband-criticizes-pharma-standortklausel-z4rzpnqc7g","count":1,"items":[{"id":"n_z4rzpnqc7gnocr6dup3a","seq":445412,"kind":"article","title":"GKV-Spitzenverband kritisiert Pharma-Standortklausel","title_en":"GKV-Spitzenverband criticizes Pharma-Standortklausel","url":"https://www.deutsche-apotheker-zeitung.de/news/artikel/2026/09/28/gkv-spitzenverband-kritisiert-pharma-standortklausel","summary":"Dass Pharmaunternehmen vom erhöhten Herstellerrabatt befreit werden könnten, wenn sie in Deutschland produzieren, ist dem GKV-Spitzenverband ein Dorn im Auge.","published":"2026-09-28T13:30:00Z","seen":"2026-09-28T14:14:27Z","lang":"de","country":"DE","source":{"id":"kite-purplemanager-com-0a68d5","name":"purplemanager.com","domain":"feeds.purplemanager.com"},"via":"kite-purplemanager-com-0a68d5","topics":["healthcare","germany","pharma-und-partner","wirtschaft"],"authors":["author"],"entities":[{"id":"Q1485795","name":"Spitzenverband Bund der Krankenkassen","type":"org"}],"image":"https://d3vhxe59evtid0.cloudfront.net/63cea2f6-fc14-445a-b7b3-4e7f2eafeff5/5dbf7f61-5a2d-406f-9e95-25dbc54508f8/b4f5f3ee-8ddb-4d0f-ba22-ed2c6731bb84/thumbnails/4c4faa5a-54e0-4f02-84ea-0e05331d5aa6.jpg?appId=ea56c88a-122b-43f9-8b91-baa17657ba48&platform=WEB","story":"st_z4rzpnqc7gnocr6dup3a","category":"politics","category_p":0.25999999046325684,"category2":"health","sentiment":"negative","tone":-0.6899999976158142,"political":0.6800000071525574}]}